We don't know whether the most recent response to this request contains information or not – if you are Grant Collingwood please sign in and let everyone know.

Valneva VLA2001 Covid-19 Vaccination Clinical Trialists

Grant Collingwood made this Official Information request to Chris Hipkins

This request has an unknown status. We're waiting for Grant Collingwood to read a recent response and update the status.

From: Grant Collingwood

October 23, 2021

Dear Chris Hipkins,

300 people in NZ are on the medsafe approved one year clinical trial of Valneva VLA2001, and they have had two vaccinations 28 days apart, followed with immunisation blood tests confirming antibodies at day 43. The clinical trial continues for a year to check the longevity of the immunity, and does not allow for other Covid-19 vaccines during the trial, as this would affect the ongoing tests.

Where antibodies for Covid-19 are present, showing immunity, will these people be provided with the NZ Domestic Vaccine Certificate showing the vaccines, or an exemption so they can go about their lives this summer, based on the traffic light settings.

Yours faithfully,

Grant Collingwood
Hamilton
New Zealand

Link to this

From: C Hipkins (MIN)
Chris Hipkins

October 23, 2021

Kia ora

Thank you for taking the time to write to Hon Chris Hipkins, Minister for
COVID-19 Response, Minister of Education, Minister for the Public Sector
and Leader of the House.

We are receiving a significant amount of correspondence at the moment and,
although your email will be carefully considered and noted, it is not
possible to respond to each individual email. However, please note that
this is an automatic response and we will endeavour to respond to your
individual queries as soon as we can.

You can find the latest information and guidance about Alert Levels at
[1]https://covid19.govt.nz/alert-levels-and...
The locations of interest are set out
at [2]https://www.health.govt.nz/our-work/dise...
encourage anyone who has been at one of the locations of interest at the
time specified to self-isolate and call Healthline on 0800 358 5453. You
can find the nearest testing centre to you
at [3]https://www.healthpoint.co.nz/covid-19/.

We appreciate that this is a challenging time. If you need to talk, you
can call or text 1737 at any time. Mental health and wellbeing resources
are also available
at [4]https://www.health.govt.nz/our-work/dise...
about the financial support available to individuals and businesses can be
found at [5]https://covid19.govt.nz/business-and-mon....

We also understand that there are several other aspects to the response
that are very important to people. You can find more information about:

o Managed Isolation and Quarantine (MIQ)
at [6]https://www.miq.govt.nz/, including how to request an emergency
allocation
at [7]https://www.miq.govt.nz/travel-to-new-ze...
make a complaint or request a review of your application by
emailing [8]https://www.miq.govt.nz/about/contact-us....
o Travel with Australia
at [9]https://covid19.govt.nz/travel/quarantin...
you are in Australia, please register
at [10]https://www.safetravel.govt.nz/ and if it is an emergency,
contact the Consulate on +64 99 20 20 20.
o Vaccines at [11]https://covid19.govt.nz/covid-19-vaccines/, including
how to book your vaccine
at [12]https://bookmyvaccine.covid19.health.nz/... by calling 0800 28
29 26.
o Vaccine data and statistics
at [13]https://www.health.govt.nz/our-work/dise...
Medsafe’s vaccine safety monitoring reports
at [14]https://www.medsafe.govt.nz/COVID-19/vac...
o The Government’s plan to reconnect New Zealand with the rest of the
world
at [16]https://covid19.govt.nz/reconnecting-new....

Please remember to take care, and be kind. We have beaten COVID-19 before,
and we can do it again.

Ngā mihi,

Office of Hon Chris Hipkins

Minister for COVID-19 Response | Minister of Education | Minister for the
Public Sector | Leader of the House | MP for Remutaka

--------------------------------------------------------------------------

References

Visible links
1. https://covid19.govt.nz/alert-levels-and...
2. https://www.health.govt.nz/our-work/dise...
3. https://www.healthpoint.co.nz/covid-19/
4. https://www.health.govt.nz/our-work/dise...
5. https://covid19.govt.nz/business-and-mon...
6. https://www.miq.govt.nz/
7. https://www.miq.govt.nz/travel-to-new-ze...
8. https://www.miq.govt.nz/about/contact-us...
9. https://covid19.govt.nz/travel/quarantin...
10. https://www.safetravel.govt.nz/
11. https://covid19.govt.nz/covid-19-vaccines/
12. https://bookmyvaccine.covid19.health.nz/
13. https://www.health.govt.nz/our-work/dise...
14. https://www.medsafe.govt.nz/COVID-19/vac...
15. file:///C:/Users/TasolaM/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/556O8F80/Updated%20Document1.docx
16. https://covid19.govt.nz/reconnecting-new...

hide quoted sections

Link to this

From: Grant Collingwood

November 02, 2021

Dear Chris Hipkins,

Please consider this request. We are very focussed on Clinical Trials for testing vaccines, and want to see this trial complete. The Valneva VLA2001 Clinical Trial is underway, and will finish in September 2022. The trialists are double vaccinated, and confirmed as having immunity. We need to be able to live normal lives in NZ during this time.

The UK Government has produced a statement confirming trialists:
"..The Department of Health and Social Care makes a firm commitment to all volunteers in formally approved COVID-19 vaccine trials in the UK that you will not be disadvantaged in terms of any future domestic vaccine certification, if introduced, compared to anyone else who has had their vaccines under the standard NHS programme.."

and
From the G7 Health Ministers’ Meeting, June 2021: communique:

"We should work to ensure that processes and national certification policies do not disadvantage certain groups of people, while retaining effective controls on the potential transmission of variants of concern and variants of interest. This includes working to ensure that participants in vaccine clinical trials are not disadvantaged."

Would please give this your urgent support, so that the Ministry of Health understand the importance of this requirement.

Yours faithfully,

Grant Collingwood

Link to this

From: C Hipkins (MIN)
Chris Hipkins

November 02, 2021

Link to this

From: Tiffany Vail

November 08, 2021

Kia ora Grant

Thank you for your email received on 2 November 2021 in which you submitted a request under the Official Information Act 1982 (the Act) to Hon Chris Hipkins, Minister for COVID-19 Response. You have requested:

"Please consider this request. We are very focussed on Clinical Trials for testing vaccines, and want to see this trial complete. The Valneva VLA2001 Clinical Trial is underway, and will finish in September 2022. The trialists are double vaccinated, and confirmed as having immunity. We need to be able to live normal lives in NZ during this time.

The UK Government has produced a statement confirming trialists:
"..The Department of Health and Social Care makes a firm commitment to all volunteers in formally approved COVID-19 vaccine trials in the UK that you will not be disadvantaged in terms of any future domestic vaccine certification, if introduced, compared to anyone else who has had their vaccines under the standard NHS programme.."

And from the G7 Health Ministers’ Meeting, June 2021: communique:

"We should work to ensure that processes and national certification policies do not disadvantage certain groups of people, while retaining effective controls on the potential transmission of variants of concern and variants of interest. This includes working to ensure that participants in vaccine clinical trials are not disadvantaged."

Would please give this your urgent support, so that the Ministry of Health understand the importance of this requirement."

Pursuant to section 15 (1) of the Act, we will endeavour to respond to your request as soon as possible, and no later than 30 November 2021 being 20 working days after the day your request was received. If we are unable to respond to your request within this timeframe, we will notify you of an extension of that timeframe.

Ngā mihi

Tiffany Vail | Private Secretary, Health
Office of Hon Chris Hipkins
Minister for COVID-19 Response

-----Original Message-----
From: Grant Collingwood [mailto:[FOI #17308 email]]
Sent: Tuesday, 2 November 2021 10:41 AM
To: C Hipkins (MIN) <[Chris Hipkins request email]>
Subject: Re: Official Information request - Valneva VLA2001 Covid-19 Vaccination Clinical Trialists - Ref: OIA0429

Dear Chris Hipkins,

Please consider this request. We are very focussed on Clinical Trials for testing vaccines, and want to see this trial complete. The Valneva VLA2001 Clinical Trial is underway, and will finish in September 2022. The trialists are double vaccinated, and confirmed as having immunity. We need to be able to live normal lives in NZ during this time.

The UK Government has produced a statement confirming trialists:
"..The Department of Health and Social Care makes a firm commitment to all volunteers in formally approved COVID-19 vaccine trials in the UK that you will not be disadvantaged in terms of any future domestic vaccine certification, if introduced, compared to anyone else who has had their vaccines under the standard NHS programme.."

and
From the G7 Health Ministers’ Meeting, June 2021: communique:

"We should work to ensure that processes and national certification policies do not disadvantage certain groups of people, while retaining effective controls on the potential transmission of variants of concern and variants of interest. This includes working to ensure that participants in vaccine clinical trials are not disadvantaged."

Would please give this your urgent support, so that the Ministry of Health understand the importance of this requirement.

Yours faithfully,

Grant Collingwood

-----Original Message-----

Kia ora

Thank you for taking the time to write to Hon Chris Hipkins, Minister for
COVID-19 Response, Minister of Education, Minister for the Public Sector and Leader of the House.

We are receiving a significant amount of correspondence at the moment and, although your email will be carefully considered and noted, it is not possible to respond to each individual email. However, please note that this is an automatic response and we will endeavour to respond to your individual queries as soon as we can.

You can find the latest information and guidance about Alert Levels at [1]https://covid19.govt.nz/alert-levels-and...
The locations of interest are set out
at [2]https://www.health.govt.nz/our-work/dise.... We encourage anyone who has been at one of the locations of interest at the time specified to self-isolate and call Healthline on 0800 358 5453. You can find the nearest testing centre to you at [3]https://www.healthpoint.co.nz/covid-19/.

We appreciate that this is a challenging time. If you need to talk, you can call or text 1737 at any time. Mental health and wellbeing resources are also available at [4]https://www.health.govt.nz/our-work/dise.... Information about the financial support available to individuals and businesses can be found at [5]https://covid19.govt.nz/business-and-mon....

We also understand that there are several other aspects to the response that are very important to people. You can find more information about:

o Managed Isolation and Quarantine (MIQ) at [6]https://www.miq.govt.nz/, including how to request an emergency allocation at [7]https://www.miq.govt.nz/travel-to-new-ze... or make a complaint or request a review of your application by emailing [8]https://www.miq.govt.nz/about/contact-us....
o Travel with Australia
at [9]https://covid19.govt.nz/travel/quarantin.... If you are in Australia, please register at [10]https://www.safetravel.govt.nz/ and if it is an emergency, contact the Consulate on +64 99 20 20 20.
o Vaccines at [11]https://covid19.govt.nz/covid-19-vaccines/, including how to book your vaccine at [12]https://bookmyvaccine.covid19.health.nz/ or by calling 0800 28
29 26.
o Vaccine data and statistics
at [13]https://www.health.govt.nz/our-work/dise... and Medsafe’s vaccine safety monitoring reports at [14]https://www.medsafe.govt.nz/COVID-19/vac... [15][MH1] o The Government’s plan to reconnect New Zealand with the rest of the world at [16]https://covid19.govt.nz/reconnecting-new....

Please remember to take care, and be kind. We have beaten COVID-19 before, and we can do it again.

Ngā mihi,

Office of Hon Chris Hipkins

Minister for COVID-19 Response | Minister of Education | Minister for the Public Sector | Leader of the House | MP for Remutaka

-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #17308 email]

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

________________________________

hide quoted sections

Link to this

From: Tiffany Vail

November 18, 2021

Kia ora Grant

Thank you for your email of 2 November 2021 in which you submitted a request under the Official Information Act 1982 (the Act) to Hon Chris Hipkins, Minister for COVID-19 Response regarding support for the Valneva VLA2001 Covid-19 Vaccination Clinical Trialists. We appreciate your interest in this matter.

The Ministry of Health has now published its Policy Statement on COVID-19 Trial Vaccinations and Vaccination Certificates. You can read the Policy Statement here: https://www.health.govt.nz/system/files/...

People who are participating in Medsafe approved COVID-19 vaccine clinical trials, and are not receiving a placebo, will be eligible for a COVID-19 Domestic Vaccine Pass or International Travel Vaccination Certificate if they are granted a temporary medical exemption.

Information on how to apply for a medical exemption is available here:
https://www.health.govt.nz/our-work/dise...

People receiving a placebo would not be eligible to receive a temporary medical exemption and would need a full primary course of a Medsafe-approved vaccine, such as Pfizer, to access a Domestic Pass or International Certificate. This should be discussed with a registered health care professional.

Under section 28(3) of the Act you have the right to ask the Ombudsman to review any decisions made under this request. The Ombudsman may be contacted by email at: [email address] or by phone on 0800 802 602.

Thank you for sharing your views with the Minister.

Ngā mihi

Tiffany Vail | Private Secretary, Health
Office of Hon Chris Hipkins
Minister for COVID-19 Response

-----Original Message-----
From: Tiffany Vail
Sent: Monday, 8 November 2021 8:37 AM
To: '[FOI #17308 email]' <[FOI #17308 email]>
Cc: C Hipkins (MIN) <[Chris Hipkins request email]>
Subject: RE: Official Information request - Valneva VLA2001 Covid-19 Vaccination Clinical Trialists - Ref: CHOIA150

Kia ora Grant

Thank you for your email received on 2 November 2021 in which you submitted a request under the Official Information Act 1982 (the Act) to Hon Chris Hipkins, Minister for COVID-19 Response. You have requested:

"Please consider this request. We are very focussed on Clinical Trials for testing vaccines, and want to see this trial complete. The Valneva VLA2001 Clinical Trial is underway, and will finish in September 2022. The trialists are double vaccinated, and confirmed as having immunity. We need to be able to live normal lives in NZ during this time.

The UK Government has produced a statement confirming trialists:
"..The Department of Health and Social Care makes a firm commitment to all volunteers in formally approved COVID-19 vaccine trials in the UK that you will not be disadvantaged in terms of any future domestic vaccine certification, if introduced, compared to anyone else who has had their vaccines under the standard NHS programme.."

And from the G7 Health Ministers’ Meeting, June 2021: communique:

"We should work to ensure that processes and national certification policies do not disadvantage certain groups of people, while retaining effective controls on the potential transmission of variants of concern and variants of interest. This includes working to ensure that participants in vaccine clinical trials are not disadvantaged."

Would please give this your urgent support, so that the Ministry of Health understand the importance of this requirement."

Pursuant to section 15 (1) of the Act, we will endeavour to respond to your request as soon as possible, and no later than 30 November 2021 being 20 working days after the day your request was received. If we are unable to respond to your request within this timeframe, we will notify you of an extension of that timeframe.

Ngā mihi

Tiffany Vail | Private Secretary, Health Office of Hon Chris Hipkins Minister for COVID-19 Response

-----Original Message-----
From: Grant Collingwood [mailto:[FOI #17308 email]]
Sent: Tuesday, 2 November 2021 10:41 AM
To: C Hipkins (MIN) <[Chris Hipkins request email]>
Subject: Re: Official Information request - Valneva VLA2001 Covid-19 Vaccination Clinical Trialists - Ref: OIA0429

Dear Chris Hipkins,

Please consider this request. We are very focussed on Clinical Trials for testing vaccines, and want to see this trial complete. The Valneva VLA2001 Clinical Trial is underway, and will finish in September 2022. The trialists are double vaccinated, and confirmed as having immunity. We need to be able to live normal lives in NZ during this time.

The UK Government has produced a statement confirming trialists:
"..The Department of Health and Social Care makes a firm commitment to all volunteers in formally approved COVID-19 vaccine trials in the UK that you will not be disadvantaged in terms of any future domestic vaccine certification, if introduced, compared to anyone else who has had their vaccines under the standard NHS programme.."

and
From the G7 Health Ministers’ Meeting, June 2021: communique:

"We should work to ensure that processes and national certification policies do not disadvantage certain groups of people, while retaining effective controls on the potential transmission of variants of concern and variants of interest. This includes working to ensure that participants in vaccine clinical trials are not disadvantaged."

Would please give this your urgent support, so that the Ministry of Health understand the importance of this requirement.

Yours faithfully,

Grant Collingwood

-----Original Message-----

Kia ora

Thank you for taking the time to write to Hon Chris Hipkins, Minister for
COVID-19 Response, Minister of Education, Minister for the Public Sector and Leader of the House.

We are receiving a significant amount of correspondence at the moment and, although your email will be carefully considered and noted, it is not possible to respond to each individual email. However, please note that this is an automatic response and we will endeavour to respond to your individual queries as soon as we can.

You can find the latest information and guidance about Alert Levels at [1]https://covid19.govt.nz/alert-levels-and...
The locations of interest are set out
at [2]https://www.health.govt.nz/our-work/dise.... We encourage anyone who has been at one of the locations of interest at the time specified to self-isolate and call Healthline on 0800 358 5453. You can find the nearest testing centre to you at [3]https://www.healthpoint.co.nz/covid-19/.

We appreciate that this is a challenging time. If you need to talk, you can call or text 1737 at any time. Mental health and wellbeing resources are also available at [4]https://www.health.govt.nz/our-work/dise.... Information about the financial support available to individuals and businesses can be found at [5]https://covid19.govt.nz/business-and-mon....

We also understand that there are several other aspects to the response that are very important to people. You can find more information about:

o Managed Isolation and Quarantine (MIQ) at [6]https://www.miq.govt.nz/, including how to request an emergency allocation at [7]https://www.miq.govt.nz/travel-to-new-ze... or make a complaint or request a review of your application by emailing [8]https://www.miq.govt.nz/about/contact-us....
o Travel with Australia
at [9]https://covid19.govt.nz/travel/quarantin.... If you are in Australia, please register at [10]https://www.safetravel.govt.nz/ and if it is an emergency, contact the Consulate on +64 99 20 20 20.
o Vaccines at [11]https://covid19.govt.nz/covid-19-vaccines/, including how to book your vaccine at [12]https://bookmyvaccine.covid19.health.nz/ or by calling 0800 28
29 26.
o Vaccine data and statistics
at [13]https://www.health.govt.nz/our-work/dise... and Medsafe’s vaccine safety monitoring reports at [14]https://www.medsafe.govt.nz/COVID-19/vac... [15][MH1] o The Government’s plan to reconnect New Zealand with the rest of the world at [16]https://covid19.govt.nz/reconnecting-new....

Please remember to take care, and be kind. We have beaten COVID-19 before, and we can do it again.

Ngā mihi,

Office of Hon Chris Hipkins

Minister for COVID-19 Response | Minister of Education | Minister for the Public Sector | Leader of the House | MP for Remutaka

-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #17308 email]

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

________________________________

hide quoted sections

Link to this

We don't know whether the most recent response to this request contains information or not – if you are Grant Collingwood please sign in and let everyone know.

Things to do with this request

Anyone:

Add an annotation (to help the requester or others)
Download a zip file of all correspondence

Grant Collingwood only:

Chris Hipkins only:

Respond to request

FYI

Valneva VLA2001 Covid-19 Vaccination Clinical Trialists

From: Grant Collingwood

October 23, 2021

From: C Hipkins (MIN)
Chris Hipkins

October 23, 2021

From: Grant Collingwood

November 02, 2021

From: C Hipkins (MIN)
Chris Hipkins

November 02, 2021

From: Tiffany Vail

November 08, 2021

From: Tiffany Vail

November 18, 2021

Things to do with this request

Follow this request

Offensive? Unsuitable?

Act on what you've learnt

Similar requests

Official Information request - Novavax and Valneva

Pfizer vaccine for children, and status for vaccine trial participants

Exemptions and AstraZeneca data

Request for communications between Chris Hipkins and the Medical Council of NZ relating to Covid19 2020-21

COVID-19 inoculations and culpability for human rights violations, crimes against humanity, and/or war crimes

Availability of alternative vaccines

COVID-19 Vaccine Technical Advisory Group meeting minutes

Informed Consent

Astra Zeneca

NVX-CoV2373, Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine

Valneva VLA2001 Covid-19 Vaccination Clinical Trialists

From: Grant Collingwood October 23, 2021

From: C Hipkins (MIN) Chris Hipkins October 23, 2021

From: Grant Collingwood November 02, 2021

From: C Hipkins (MIN) Chris Hipkins November 02, 2021

From: Tiffany Vail November 08, 2021

From: Tiffany Vail November 18, 2021

Things to do with this request

Follow this request

Offensive? Unsuitable?

Act on what you've learnt

Similar requests

From: Grant Collingwood

October 23, 2021

From: C Hipkins (MIN)
Chris Hipkins

October 23, 2021

From: Grant Collingwood

November 02, 2021

From: C Hipkins (MIN)
Chris Hipkins

November 02, 2021

From: Tiffany Vail

November 08, 2021

From: Tiffany Vail

November 18, 2021